Pharmaceutical Development and Technology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.9 | Q2 | 51.7% | 0.471 | Q2 | 58.8% |
| 2024 | 2.5 | Q3 | 49.0% | 0.463 | Q2 | 59.7% |
| 2023 | 2.6 | Q2 | 52.4% | 0.476 | Q2 | 63.3% |
| 2022 | 3.4 | Q2 | 62.5% | 0.481 | Q2 | 65.2% |
| 2021 | 3.9 | Q2 | 66.6% | 0.511 | Q2 | 67.8% |
| 2020 | — | — | 0.511 | Q2 | 66.9% | |
| 2019 | — | — | 0.441 | Q2 | 63.8% | |
| 2018 | — | — | 0.594 | Q2 | 70.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1097-9867
ISSN
1083-7450
region
Western Europe
coverage
1996-2026